Meeting

COT Meeting: 12th July 2022

Agenda and papers for the meeting of the Committee at 10.00am on Tuesday 12th July 2022

Last updated: 07 December 2022

Meeting Agenda

  1. Apologies for absence. 
  2. Draft minutes and reserved minutes of the 10th May      TOX/MIN/2022/04.
  3. Matters arising.
  4.  Discussion paper on the potential risk to human health of turmeric and curcumin supplements – following an updated literature review TOX/2022/35.
  5.  The potential risks from ergot alkaloids in the TOX/2022/36 maternal diet: Discussion paper.
  6. Discussion paper on Ocean Bound Plastic TOX/2022/3.
  7. Statement on the bioavailability of nicotine from the use of oral nicotine pouches and assessment of the potential toxicological risk to users – First Draft TOX/2022/38
  8. EFSA consultation: Discussion paper on review of existing Health Based Guidance Values for copper TOX/2022/39.
  9. Updated literature on potential health risks from organophosphate exposure in aircraft cabin air TOX/2022/40.
  10. Draft document on how the Committees evaluate the relevance and reliability of data when assessing a chemical of concern? – draft 0.e TOX/2022/41.
  11. First draft statement on the safety of ginger supplement use in pregnancy TOX/2022/42.
  12. Update on the work of other advisory committees TOX/2022/43 - for information.
  13. Any other business.

Next meeting of the Committee Tuesday 6th September, in person venue TBC and by Teams.

Matters arising:

  • Update on the process for the renewal of smoke flavourings authorisation TOX/2022/34.

Media discussed during the meeting

PDF documents on this page are not in a fully accessible format, if you require it to be fully accessible, please see the HTML link for that document.

Please see information on reserved items on the Procedure for holding COT meetings in open session page

TOX/MIN/2022/04

Draft minutes of the 10th May 2022 meeting

Draft minutes of the 10th May 2022 meeting

TOX/2022/34

Update on the process for the renewal of smoke flavourings authorisation. (Reserved)

TOX/2022/35

Discussion paper on the potential risk to human health of turmeric and curcumin supplements – following an updated literature review.      

Discussion paper on the potential risk to human health of turmeric and curcumin supplements 

Annex A to TOX/2022/35

Cover page Annex B to TOX/2022/35

Annex B to TOX/2022/35 Turmeric survey report

TOX/2022/36

The potential risks from ergot alkaloids in the maternal diet: Discussion paper.

The potential risks from ergot alkaloids in the maternal diet

TOX/2022/37

Discussion paper on Ocean Bound Plastic

TOX/2022/38

Statement on the bioavailability of nicotine from the use of oral nicotine pouches and assessment of the potential toxicological risk to users – First Draft.

First draft statement on the bioavailability of nicotine from the use of oral nicotine pouches and assessment of the potential toxicological risk to users

TOX/2022/39

EFSA consultation: Discussion paper on review of existing Health Based Guidance Values for copper.

Discussion paper on the EFSA Draft Opinion for Public Consultation on Re-evaluation of the existing health-based guidance values for copper and exposure assessment from all sources

TOX/2022/40

Updated literature on potential health risks from organophosphate exposure in aircraft cabin air

TOX/2022/41

Draft document on how the Committees evaluate the relevance and reliability of data when assessing a chemical of concern.

TOX/2022/42

First draft statement on the safety of ginger supplement use in pregnancy

TOX/2022/43

Update on the work of other advisory committees TOX/2022/43 - for information.

Update on the work of other advisory committees July 2022

Final minutes of the meeting of the Committee on 12th July 2022

Final minutes of the 12th July 2022 meeting

The final minutes of the meeting of the Committee held on Tuesday 12th July 2022